Alnylam Pharmaceuticals (ALNY) Options Chain & Prices $216.98 -2.22 (-1.01%) As of 04:00 PM Eastern Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALNY Put and Call Options List 12/17/2027 3/19/2027 1/15/2027 12/18/2026 9/18/2026 8/21/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades8/21/2026$180.00$0.333Put56 - 276(+0)61.79% (+2.45%)-0.035766108/21/2026$180.00$37.711Call20 - 205(+0)61.79% (+2.45%)0.96609678/21/2026$190.00$0.684Put5 - - 100(+0)54.79% (+0.51%)-0.073228/21/2026$195.00$1.013Put5 - - 85(+0)51.67% (-0.31%)-0.10648928/21/2026$210.00$3.718Put22 - 83(+1)45.66% (-0.95%)-0.32113928/21/2026$210.00$11.107Call9 - 7130(+4)45.66% (-0.95%)0.68405458/21/2026$220.00$8.463Put28424252(+0)46.36% (+1.48%)-0.54860688/21/2026$220.00$5.814Call115497(+8)46.36% (+1.48%)0.45953158/21/2026$230.00$3.080Call84 - 337(-3)50.39% (+5.47%)0.27715438/21/2026$240.00$1.777Call6 - 3557(-1)55.80% (+9.39%)0.16816648/21/2026$250.00$1.115Call5923500(+0)61.51% (+12.73%)0.10695912End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Regeneron Pharmaceuticals Options Data argenex Options Data Natera Options Data Revolution Medicines Options Data Biogen Options Data Insmed Options Data Roivant Sciences Options Data Incyte Options Data BioNTech Options Data Moderna Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:ALNY) was last updated on 8/10/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored$8B is moving in... are you?Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...Awesomely | SponsoredBofA: Digital Dollar Coming 2025-2030Why does the Fed keep denying a digital dollar... when the framework for "programmable money" is already publi...Decentralized Masters | SponsoredTrump's Next Move Could Shrink Your DollarThere's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. d...Priority Gold | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
